Mutational and functional analysis in human Ras/MAP kinase genetic syndromes.

William E. Tidyman, Katherine A. Rauen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Ras/mitogen-activated protein kinase (MAPK) pathway is essential in regulation of the cell cycle, cell differentiation, growth, and cell senescence, each of which are critical to normal development. A class of developmental disorders, the "RASopathies," is caused by germline mutations in genes that encode protein components of the Ras/MAPK pathway which result in dysregulation of the pathway and profound deleterious effects on development. One of these syndromes, cardiofaciocutaneous (CFC) syndrome, is caused by germline mutations in BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2), and possibly KRAS genes. Here, we describe the laboratory protocols and methods that we used to identify mutations in BRAF and MEK1/2 genes as causative for CFC syndrome. In addition, we present the techniques used to determine the effect these mutations have on activity of the Ras/MAPK pathway through Western blot analysis of the phosphorylation of endogenous ERK1/2, as well as through the use of an in vitro kinase assay that measures the phosphorylation of Elk-1.

Original languageEnglish (US)
Pages (from-to)433-447
Number of pages15
JournalMethods in molecular biology (Clifton, N.J.)
Volume661
StatePublished - 2010

Fingerprint

Mitogen-Activated Protein Kinases
Phosphotransferases
Germ-Line Mutation
Phosphorylation
Mutation
Cell Aging
Genes
Cell Differentiation
Cell Cycle
Western Blotting
Growth
Proteins
Cardiofaciocutaneous syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mutational and functional analysis in human Ras/MAP kinase genetic syndromes. / Tidyman, William E.; Rauen, Katherine A.

In: Methods in molecular biology (Clifton, N.J.), Vol. 661, 2010, p. 433-447.

Research output: Contribution to journalArticle

@article{626dc9aec24d425897eabd97c1d9bd09,
title = "Mutational and functional analysis in human Ras/MAP kinase genetic syndromes.",
abstract = "The Ras/mitogen-activated protein kinase (MAPK) pathway is essential in regulation of the cell cycle, cell differentiation, growth, and cell senescence, each of which are critical to normal development. A class of developmental disorders, the {"}RASopathies,{"} is caused by germline mutations in genes that encode protein components of the Ras/MAPK pathway which result in dysregulation of the pathway and profound deleterious effects on development. One of these syndromes, cardiofaciocutaneous (CFC) syndrome, is caused by germline mutations in BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2), and possibly KRAS genes. Here, we describe the laboratory protocols and methods that we used to identify mutations in BRAF and MEK1/2 genes as causative for CFC syndrome. In addition, we present the techniques used to determine the effect these mutations have on activity of the Ras/MAPK pathway through Western blot analysis of the phosphorylation of endogenous ERK1/2, as well as through the use of an in vitro kinase assay that measures the phosphorylation of Elk-1.",
author = "Tidyman, {William E.} and Rauen, {Katherine A.}",
year = "2010",
language = "English (US)",
volume = "661",
pages = "433--447",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Mutational and functional analysis in human Ras/MAP kinase genetic syndromes.

AU - Tidyman, William E.

AU - Rauen, Katherine A.

PY - 2010

Y1 - 2010

N2 - The Ras/mitogen-activated protein kinase (MAPK) pathway is essential in regulation of the cell cycle, cell differentiation, growth, and cell senescence, each of which are critical to normal development. A class of developmental disorders, the "RASopathies," is caused by germline mutations in genes that encode protein components of the Ras/MAPK pathway which result in dysregulation of the pathway and profound deleterious effects on development. One of these syndromes, cardiofaciocutaneous (CFC) syndrome, is caused by germline mutations in BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2), and possibly KRAS genes. Here, we describe the laboratory protocols and methods that we used to identify mutations in BRAF and MEK1/2 genes as causative for CFC syndrome. In addition, we present the techniques used to determine the effect these mutations have on activity of the Ras/MAPK pathway through Western blot analysis of the phosphorylation of endogenous ERK1/2, as well as through the use of an in vitro kinase assay that measures the phosphorylation of Elk-1.

AB - The Ras/mitogen-activated protein kinase (MAPK) pathway is essential in regulation of the cell cycle, cell differentiation, growth, and cell senescence, each of which are critical to normal development. A class of developmental disorders, the "RASopathies," is caused by germline mutations in genes that encode protein components of the Ras/MAPK pathway which result in dysregulation of the pathway and profound deleterious effects on development. One of these syndromes, cardiofaciocutaneous (CFC) syndrome, is caused by germline mutations in BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2), and possibly KRAS genes. Here, we describe the laboratory protocols and methods that we used to identify mutations in BRAF and MEK1/2 genes as causative for CFC syndrome. In addition, we present the techniques used to determine the effect these mutations have on activity of the Ras/MAPK pathway through Western blot analysis of the phosphorylation of endogenous ERK1/2, as well as through the use of an in vitro kinase assay that measures the phosphorylation of Elk-1.

UR - http://www.scopus.com/inward/record.url?scp=79952112081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952112081&partnerID=8YFLogxK

M3 - Article

C2 - 20812000

AN - SCOPUS:79952112081

VL - 661

SP - 433

EP - 447

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -